TOFFANIN, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 984
EU - Europa 700
AS - Asia 537
OC - Oceania 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.229
Nazione #
US - Stati Uniti d'America 966
CN - Cina 478
IE - Irlanda 282
IT - Italia 154
FI - Finlandia 74
DE - Germania 61
UA - Ucraina 42
SE - Svezia 29
SG - Singapore 26
IN - India 25
GB - Regno Unito 23
CA - Canada 18
BE - Belgio 12
RU - Federazione Russa 9
FR - Francia 6
AU - Australia 5
CZ - Repubblica Ceca 3
ES - Italia 3
AR - Argentina 2
ID - Indonesia 2
JP - Giappone 2
EU - Europa 1
HK - Hong Kong 1
IQ - Iraq 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
TW - Taiwan 1
Totale 2.229
Città #
Dublin 282
Chandler 261
Beijing 99
Nanjing 98
Jacksonville 80
Pavia 70
Ashburn 67
Ann Arbor 61
Nanchang 53
Princeton 44
Lawrence 42
Medford 42
Wilmington 38
Shenyang 33
Helsinki 32
Shanghai 32
Hebei 30
Changsha 28
Jiaxing 26
Hangzhou 23
Pune 20
Piscataway 17
Tianjin 17
Toronto 14
Dearborn 13
Singapore 13
Woodbridge 13
Brussels 12
Boardman 10
Rome 10
Los Angeles 9
Cameri 7
Seattle 7
Busto Garolfo 6
Jinan 6
Redwood City 6
Fairfield 5
Ningbo 5
Norwalk 5
Guangzhou 4
New York 4
Ottawa 4
San Francisco 4
Sesto Calende 4
Houston 3
Kunming 3
Thousand Oaks 3
Zhengzhou 3
Andover 2
Augusta 2
Bangalore 2
Bergamo 2
Berlin 2
Brighton 2
Cambridge 2
Caselle Torinese 2
Des Moines 2
Florence 2
Frankfurt am Main 2
Garden Grove 2
Jilin City 2
Meda 2
Milan 2
Monells 2
Olomouc 2
Reims 2
Santa Fe 2
Sydney 2
Taizhou 2
Tokyo 2
Washington 2
Westminster 2
Ala 1
Albiate 1
Amsterdam 1
Atlanta 1
Baoding 1
Barcelona 1
Bari 1
Bovisio Masciago 1
Chioggia 1
Cinisello Balsamo 1
Clifton 1
Cologno Monzese 1
Como 1
Dalmine 1
Fayetteville 1
Gunzenhausen 1
Kemerovo 1
Kyjov 1
Langfang 1
Lecce 1
Legnano 1
Mantova 1
Miami 1
Mulazzano 1
Orange 1
Padova 1
Quanzhou 1
Redmond 1
Totale 1.744
Nome #
MPC-based artificial pancreas: Strategies for individualization and meal compensation 98
Artificial pancreas: Model predictive control design from clinical experience 84
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas 83
Designing an artificial pancreas architecture: the AP@home experience. 81
Embedded implementation of modular closed-loop control of diabetes and in silico validation2013 IEEE 15th International Conference on e-Health Networking, Applications and Services (Healthcom 2013) 81
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 81
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 71
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 67
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia 66
Automatic adaptation of basal therapy for Type 1 diabetic patients: A Run-to-Run approach 66
Model Predictive Control of Type 1 diabetes added to conventional therapy 65
Postprandial glucose regulation via KNN meal classification in type 1 diabetes 64
Method for controlling the delivery of insulin and related system 63
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 62
Towards a Run-to-Run Adaptive Artificial Pancreas: In Silico Results 61
A nonparametric approach for model individualization in an artificial pancreas 60
Glucose-insulin model identified in free-living conditions for hypoglycaemia prevention 57
Monitoring Artificial Pancreas Trials Through Agent-based Technologies: A Case Report 55
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 55
Service pressure regulation in water distribution networks 54
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 51
Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management 51
Therapy-driven Deep Glucose Forecasting 48
Model predictive control with integral action for artificial pancreas 47
Multiple models for artificial pancreas predictions identified from free-living condition data: A proof of concept study 47
Model individualization for artificial pancreas 45
Towards a Model-Based Field-Frequency Lock for NMR 45
Dynamic insulin on board: Incorporation of circadian insulin sensitivity variation 45
Method for controlling the delivery of insulin and the related system 43
MPC Model Individualization in Free-Living Conditions: A Proof-of-Concept Case Study 43
Hypoglycemia Prevention via Personalized Glucose-Insulin Models Identified in Free-Living Conditions 41
Model-based identification of eating behavioral patterns in populations with type 1 diabetes 38
Artificial Pancreas: from Control-to-Range to Control-to-Target 37
Modular Closed-Loop Control of Diabetes 36
Improving diabetes conventional therapy via machine learning modeling 36
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes 30
Run-to-Run Tuning of Model Predictive Control for Type I Diabetic Subjects: in silico trial 30
Towards a Model-Based Field-Frequency Lock for Fast-Field Cycling NMR 30
Improvement of manufacturing technologies through a modelling approach: An air-steam sterilization case-study 29
Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites 28
Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling 28
Scalable model for industrial coffee roasting chamber 27
Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery 26
In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems 26
In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing 15
Pulsatile Zone MPC with asymmetric stationary cost for artificial pancreas based on a non-standard IOB constraint 10
Combining clustering and regularised neural network for burst detection and localization and flow/pressure sensor placement in water distribution networks 9
Personalized LSTM-based alarm systems for hypoglycemia and hyperglycemia prevention 9
Run-to-Run algorithm for clinical decision support: In silico study for a personalized adaptation of the basal-bolus therapy and of the visit scheduling 8
Constrained Versus Unconstrained Model Predictive Control for Artificial Pancreas 5
LSTM Network for the Oxygen Concentration Modeling of a Wastewater Treatment Plant 4
Human Digital Twin for Personalized Elderly Type 2 Diabetes Management 4
Totale 2.345
Categoria #
all - tutte 9.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020527 131 207 8 25 8 12 11 16 2 64 43 0
2020/2021193 16 7 4 21 8 21 6 30 41 25 11 3
2021/2022282 7 2 14 8 4 9 6 7 18 13 32 162
2022/2023795 112 66 13 49 65 64 1 40 328 4 49 4
2023/2024307 25 44 8 16 21 61 10 35 7 18 42 20
2024/202530 30 0 0 0 0 0 0 0 0 0 0 0
Totale 2.345